Build Your Comparison

Side-by-side financial analysis
AAMI logo
AAMI
MS logo
MS
Try popular comparisons:

Stock Comparison

AAMI vs MS

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
AAMI
Acadian Asset Management

Asset Management

Financial ServicesNYSE • US
Market Cap$2.81B
5Y Perf.+530.3%
MS
Morgan Stanley

Financial - Capital Markets

Financial ServicesNYSE • US
Market Cap$340.97B
5Y Perf.+343.1%

AAMI vs MS — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
AAMI logoAAMI
MS logoMS
IndustryAsset ManagementFinancial - Capital Markets
Market Cap$2.81B$340.97B
Revenue (TTM)$594M$114.98B
Net Income (TTM)$80M$16.86B
Gross Margin92.9%57.1%
Operating Margin27.4%19.1%
Forward P/E16.4x18.0x
Total Debt$323M$475.56B
Cash & Equiv.$101M$111.69B

AAMI vs MSLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

AAMI
MS
StockJun 20Jun 26Return
Acadian Asset Manag… (AAMI)100630.3+530.3%
Morgan Stanley (MS)100443.1+343.1%

Price return only. Dividends and distributions are not included.

Quick Verdict: AAMI vs MS

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: MS leads in 4 of 7 categories, making it the strongest pick for profitability and margin quality and capital preservation and lower volatility. Acadian Asset Management is the stronger pick specifically for growth and revenue expansion and valuation and capital efficiency. As sector peers, any of these can serve as alternatives in the same allocation.
🥇MS emerged as the overall leader. Track its performance:
AAMI
Acadian Asset Management
The Banking Pick

AAMI is the clearest fit if your priority is growth exposure and sleep-well-at-night.

  • Rev growth 17.5%, EPS growth -0.5%
  • Lower volatility, beta 1.52, current ratio 1.67x
  • 17.5% NII/revenue growth vs MS's 11.5%
Best for: growth exposure and sleep-well-at-night
MS
Morgan Stanley
The Banking Pick

MS carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.

  • Dividend streak 12 yrs, beta 1.40, yield 1.9%
  • 8.5% 10Y total return vs AAMI's 471.7%
  • Beta 1.40, yield 1.9%, current ratio 1.17x
Best for: income & stability and long-term compounding
See the full category breakdown
CategoryWinnerWhy
GrowthAAMI logoAAMI17.5% NII/revenue growth vs MS's 11.5%
ValueAAMI logoAAMILower P/E (16.4x vs 18.0x)
Quality / MarginsMS logoMSEfficiency ratio 0.4% vs AAMI's 0.7% (lower = leaner)
Stability / SafetyMS logoMSBeta 1.40 vs AAMI's 1.52
DividendsMS logoMS1.9% yield, 12-year raise streak, vs AAMI's 0.1%
Momentum (1Y)AAMI logoAAMI+148.2% vs MS's +65.3%
Efficiency (ROA)MS logoMSEfficiency ratio 0.4% vs AAMI's 0.7%

AAMI vs MS — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

AAMIAcadian Asset Management

Segment breakdown not available.

MSMorgan Stanley
FY 2025
Institutional Securities Segment
46.4%$33.1B
Wealth Management Segment
44.5%$31.8B
Investment Management Segment
9.1%$6.5B

AAMI vs MS — Financial Metrics

Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLAAMILAGGINGMS

Income & Cash Flow (Last 12 Months)

AAMI leads this category, winning 3 of 5 comparable metrics.

MS is the larger business by revenue, generating $115.0B annually — 193.5x AAMI's $594M. Profitability is closely matched — net margins range from 14.7% (MS) to 13.5% (AAMI).

MetricAAMI logoAAMIAcadian Asset Man…MS logoMSMorgan Stanley
RevenueTrailing 12 months$594M$115.0B
EBITDAEarnings before interest/tax$179M$26.6B
Net IncomeAfter-tax profit$80M$16.9B
Free Cash FlowCash after capex-$14M-$17.9B
Gross MarginGross profit ÷ Revenue+92.9%+57.1%
Operating MarginEBIT ÷ Revenue+27.4%+19.1%
Net MarginNet income ÷ Revenue+13.5%+14.7%
FCF MarginFCF ÷ Revenue-2.3%-15.6%
Rev. Growth (YoY)Latest quarter vs prior year
EPS Growth (YoY)Latest quarter vs prior year-14.2%+48.9%
AAMI leads this category, winning 3 of 5 comparable metrics.

Valuation Metrics

MS leads this category, winning 4 of 6 comparable metrics.

At 21.0x trailing earnings, MS trades at a 41% valuation discount to AAMI's 35.5x P/E. On an enterprise value basis, AAMI's 16.9x EV/EBITDA is more attractive than MS's 26.5x.

MetricAAMI logoAAMIAcadian Asset Man…MS logoMSMorgan Stanley
Market CapShares × price$2.8B$341.0B
Enterprise ValueMkt cap + debt − cash$3.0B$704.8B
Trailing P/EPrice ÷ TTM EPS35.54x20.98x
Forward P/EPrice ÷ next-FY EPS est.16.38x18.00x
PEG RatioP/E ÷ EPS growth rate2.19x
EV / EBITDAEnterprise value multiple16.88x26.49x
Price / SalesMarket cap ÷ Revenue4.72x2.97x
Price / BookPrice ÷ Book value/share33.85x3.03x
Price / FCFMarket cap ÷ FCF15.53x7.40x
MS leads this category, winning 4 of 6 comparable metrics.

Profitability & Efficiency

AAMI leads this category, winning 9 of 9 comparable metrics.

AAMI delivers a 85.4% return on equity — every $100 of shareholder capital generates $85 in annual profit, vs $15 for MS. AAMI carries lower financial leverage with a 3.84x debt-to-equity ratio, signaling a more conservative balance sheet compared to MS's 4.22x. On the Piotroski fundamental quality scale (0–9), AAMI scores 8/9 vs MS's 7/9, reflecting strong financial health.

MetricAAMI logoAAMIAcadian Asset Man…MS logoMSMorgan Stanley
ROE (TTM)Return on equity+85.4%+15.3%
ROA (TTM)Return on assets+11.5%+1.2%
ROICReturn on invested capital+29.2%+3.1%
ROCEReturn on capital employed+31.9%+3.3%
Piotroski ScoreFundamental quality 0–987
Debt / EquityFinancial leverage3.84x4.22x
Net DebtTotal debt minus cash$222M$363.9B
Cash & Equiv.Liquid assets$101M$111.7B
Total DebtShort + long-term debt$323M$475.6B
Interest CoverageEBIT ÷ Interest expense7.60x0.45x
AAMI leads this category, winning 9 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

AAMI leads this category, winning 5 of 6 comparable metrics.

A $10,000 investment in AAMI five years ago would be worth $35,390 today (with dividends reinvested), compared to $25,467 for MS. Over the past 12 months, AAMI leads with a +148.2% total return vs MS's +65.3%. The 3-year compound annual growth rate (CAGR) favors AAMI at 52.2% vs MS's 37.1% — a key indicator of consistent wealth creation.

MetricAAMI logoAAMIAcadian Asset Man…MS logoMSMorgan Stanley
YTD ReturnYear-to-date+66.2%+18.8%
1-Year ReturnPast 12 months+148.2%+65.3%
3-Year ReturnCumulative with dividends+252.6%+157.5%
5-Year ReturnCumulative with dividends+253.9%+154.7%
10-Year ReturnCumulative with dividends+471.7%+854.4%
CAGR (3Y)Annualised 3-year return+52.2%+37.1%
AAMI leads this category, winning 5 of 6 comparable metrics.

Risk & Volatility

Evenly matched — AAMI and MS each lead in 1 of 2 comparable metrics.

MS is the less volatile stock with a 1.40 beta — it tends to amplify market swings less than AAMI's 1.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500.

MetricAAMI logoAAMIAcadian Asset Man…MS logoMSMorgan Stanley
Beta (5Y)Sensitivity to S&P 5001.52x1.40x
52-Week HighHighest price in past year$79.15$219.16
52-Week LowLowest price in past year$30.98$128.81
% of 52W HighCurrent price vs 52-week peak+99.2%+97.7%
RSI (14)Momentum oscillator 0–10064.462.2
Avg Volume (50D)Average daily shares traded327K4.5M
Evenly matched — AAMI and MS each lead in 1 of 2 comparable metrics.

Analyst Outlook

MS leads this category, winning 2 of 2 comparable metrics.

Wall Street rates AAMI as "Hold" and MS as "Buy". Consensus price targets imply -6.0% upside for MS (target: $201) vs -12.6% for AAMI (target: $69). MS is the only dividend payer here at 1.93% yield — a key consideration for income-focused portfolios.

MetricAAMI logoAAMIAcadian Asset Man…MS logoMSMorgan Stanley
Analyst RatingConsensus buy/hold/sellHoldBuy
Price TargetConsensus 12-month target$68.67$201.25
# AnalystsCovering analysts352
Dividend YieldAnnual dividend ÷ price+0.1%+1.9%
Dividend StreakConsecutive years of raises012
Dividend / ShareAnnual DPS$0.04$4.14
Buyback YieldShare repurchases ÷ mkt cap+1.7%+1.7%
MS leads this category, winning 2 of 2 comparable metrics.
Key Takeaway

AAMI leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). MS leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.

Best OverallAcadian Asset Management (AAMI)Leads 3 of 6 categories
Loading custom metrics...

AAMI vs MS: Frequently Asked Questions

10 questions · data-driven answers · updated daily

01

Is AAMI or MS a better buy right now?

For growth investors, Acadian Asset Management (AAMI) is the stronger pick with 17.

5% revenue growth year-over-year, versus 11. 5% for Morgan Stanley (MS). Morgan Stanley (MS) offers the better valuation at 21. 0x trailing P/E (18. 0x forward), making it the more compelling value choice. Analysts rate Morgan Stanley (MS) a "Buy" — based on 52 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — AAMI or MS?

On trailing P/E, Morgan Stanley (MS) is the cheapest at 21.

0x versus Acadian Asset Management at 35. 5x. On forward P/E, Acadian Asset Management is actually cheaper at 16. 4x — notably different from the trailing picture, reflecting expected earnings growth.

03

Which is the better long-term investment — AAMI or MS?

Over the past 5 years, Acadian Asset Management (AAMI) delivered a total return of +253.

9%, compared to +154. 7% for Morgan Stanley (MS). Over 10 years, the gap is even starker: MS returned +854. 4% versus AAMI's +471. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — AAMI or MS?

By beta (market sensitivity over 5 years), Morgan Stanley (MS) is the lower-risk stock at 1.

40β versus Acadian Asset Management's 1. 52β — meaning AAMI is approximately 8% more volatile than MS relative to the S&P 500. On balance sheet safety, Acadian Asset Management (AAMI) carries a lower debt/equity ratio of 4% versus 4% for Morgan Stanley — giving it more financial flexibility in a downturn.

05

Which is growing faster — AAMI or MS?

By revenue growth (latest reported year), Acadian Asset Management (AAMI) is pulling ahead at 17.

5% versus 11. 5% for Morgan Stanley (MS). On earnings-per-share growth, the picture is similar: Morgan Stanley grew EPS 28. 3% year-over-year, compared to -0. 5% for Acadian Asset Management. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — AAMI or MS?

Morgan Stanley (MS) is the more profitable company, earning 14.

7% net margin versus 13. 5% for Acadian Asset Management — meaning it keeps 14. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AAMI leads at 27. 4% versus 19. 1% for MS. At the gross margin level — before operating expenses — AAMI leads at 92. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is AAMI or MS more undervalued right now?

On forward earnings alone, Acadian Asset Management (AAMI) trades at 16.

4x forward P/E versus 18. 0x for Morgan Stanley — 1. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MS: -6. 0% to $201. 25.

08

Which pays a better dividend — AAMI or MS?

In this comparison, MS (1.

9% yield) pays a dividend. AAMI does not pay a meaningful dividend and should not be held primarily for income.

09

Is AAMI or MS better for a retirement portfolio?

For long-horizon retirement investors, Morgan Stanley (MS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1.

9% yield, +854. 4% 10Y return). Acadian Asset Management (AAMI) carries a higher beta of 1. 52 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MS: +854. 4%, AAMI: +471. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between AAMI and MS?

Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: AAMI is a small-cap high-growth stock; MS is a large-cap quality compounder stock. MS pays a dividend while AAMI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.